Atracurium Besylate 00409-1105-02
- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 29, 2013
- Listing Expires
- December 31, 2026
- Application
- ANDA090761
Need to source Atracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atracurium Besylate | 10 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Selected Package
00409-1105-02Selected10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22)